Silji Abraham
Net Worth

Last updated:

What is Silji Abraham net worth?

The estimated net worth of Mr. Silji Abraham is at least $18,243,680 as of 29 Oct 2024. He owns shares worth $706,363 as insider, has earned $12,387,317 from insider trading and has received compensation worth at least $5,150,000 in West Pharmaceutical Services, Inc..

What is the salary of Silji Abraham?

Mr. Silji Abraham salary is $1,030,000 per year as Senior Vice President & Chief Technology Officer in West Pharmaceutical Services, Inc..

How old is Silji Abraham?

Mr. Silji Abraham is 53 years old, born in 1972.

What stocks does Silji Abraham currently own?

As insider, Mr. Silji Abraham owns shares in one company:

Company Title Shares Price per share Total value
West Pharmaceutical Services, Inc. (WST) Senior Vice President & Chief Technology Officer 2,860 $246.98 $706,363

What does West Pharmaceutical Services, Inc. do?

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Silji Abraham insider trading

West Pharmaceutical Services, Inc.

Mr. Silji Abraham has made 12 insider trades between 2020-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 8,160 units of WST stock on 8 Aug 2023. As of 29 Oct 2024 he still owns at least 2,860 units of WST stock.

Transaction Date Security Shares Price per share Total value Source
Option
Rst. Stock Unit 458 N/A N/A
Option
Common Stock 458 N/A N/A
Sale
Common Stock 1,800 $330.78 $595,404
Option
Common Stock 7,012 $173.22 $1,214,619
Sale
Common Stock 7,012 $365 $2,559,380
Option
Stock Options (Right to Buy) 7,012 $173.22 $1,214,619
Option
Common Stock 8,160 $102.51 $836,482
Option
Stock Options (Right to buy) 8,160 $102.51 $836,482
Sale
Common Stock 6 $397.69 $2,386
Sale
Common Stock 8,154 $397.18 $3,238,589
Sale
Common Stock 7,371 $365.55 $2,694,491
Option
Stock Options (Right to Buy) 8,020 $86.24 $691,645
Option
Common Stock 8,020 $86.24 $691,645
Sale
Common Stock 649 $366.14 $237,624
Sale
Common Stock 1,500 $322.57 $483,851
Sale
Common Stock 5,374 $343.94 $1,848,307
Sale
Common Stock 2,171 $335 $727,285
Option
Stock Options (Right to Buy) 1,000 N/A N/A
Option
Common Stock 1,000 N/A N/A
Sale
Common Stock 1,000 N/A N/A
Option
Stock Options (Right to Buy) 1,000 N/A N/A
Option
Common Stock 1,000 N/A N/A
Sale
Common Stock 1,000 N/A N/A
Option
Stock Options (Right to buy) 500 N/A N/A
Option
Common Stock 500 N/A N/A
Sale
Common Stock 500 N/A N/A

West Pharmaceutical Services key executives

West Pharmaceutical Services, Inc. executives and other stock owners filed with the SEC: